Agilent Technologies, Inc. (A)
150.86
+0.88
(+0.59%)
USD |
NYSE |
Sep 04, 16:00
150.90
+0.04
(+0.03%)
After-Hours: 20:00
Agilent Technologies Research and Development Expense (Quarterly) : 120.00M for July 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 120.00M |
| April 30, 2026 | 126.00M |
| January 31, 2026 | 117.00M |
| October 31, 2025 | 117.00M |
| July 31, 2025 | 111.00M |
| April 30, 2025 | 109.00M |
| January 31, 2025 | 107.00M |
| October 31, 2024 | 110.00M |
| July 31, 2024 | 109.00M |
| April 30, 2024 | 113.00M |
| January 31, 2024 | 120.00M |
| October 31, 2023 | 114.00M |
| July 31, 2023 | 118.00M |
| April 30, 2023 | 126.00M |
| January 31, 2023 | 123.00M |
| October 31, 2022 | 119.00M |
| July 31, 2022 | 116.00M |
| April 30, 2022 | 115.00M |
| January 31, 2022 | 117.00M |
| October 31, 2021 | 116.00M |
| July 31, 2021 | 113.00M |
| April 30, 2021 | 109.00M |
| January 31, 2021 | 103.00M |
| October 31, 2020 | 101.00M |
| July 31, 2020 | 92.00M |
| Date | Value |
|---|---|
| April 30, 2020 | 100.00M |
| January 31, 2020 | 104.00M |
| October 31, 2019 | 102.00M |
| July 31, 2019 | 101.00M |
| April 30, 2019 | 99.00M |
| January 31, 2019 | 102.00M |
| October 31, 2018 | 104.00M |
| July 31, 2018 | 97.00M |
| April 30, 2018 | 92.00M |
| January 31, 2018 | 93.00M |
| October 31, 2017 | 89.00M |
| July 31, 2017 | 87.00M |
| April 30, 2017 | 84.00M |
| January 31, 2017 | 79.00M |
| October 31, 2016 | 84.00M |
| July 31, 2016 | 82.00M |
| April 30, 2016 | 81.00M |
| January 31, 2016 | 78.00M |
| October 31, 2015 | 82.00M |
| July 31, 2015 | 79.00M |
| April 30, 2015 | 81.00M |
| January 31, 2015 | 88.00M |
| October 31, 2014 | 97.00M |
| July 31, 2014 | 86.00M |
| April 30, 2014 | 176.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Danaher Corp. | 412.00M |
| Thermo Fisher Scientific, Inc. | 364.00M |
| Waters Corp. | 121.00M |
| Illumina, Inc. | 257.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |